| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |